Clinical Trial Update: Phase 1, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SM04690 in Moderate to Severe Knee Osteoarthritis (OA) [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of SM04690 in patients with moderate-to-severe knee o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• SM04690 (SM04690)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Moderate to Severe Osteoarthritis | Phase 1 | Status: COMPLETED